NCT07226492 is a NA clinical trial of Unconditional Cash Transfer (UCT) in HIV, sponsored by University of Pennsylvania.

Who is sponsoring NCT07226492?

NCT07226492 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT07226492?

Interventions in NCT07226492: Unconditional Cash Transfer (UCT).

What condition does NCT07226492 study?

NCT07226492 studies HIV, Pregnancy, HIV Antiretroviral Therapy (ART) Adherence, Post-partum.

Is NCT07226492 still recruiting?

NCT07226492 is currently recruiting now. Last updated 13 March 2026.

Last reviewed 2026-03-13 · How we verify

NCT07226492

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cash Transfers to Pregnant Women With HIV

Recruiting now NA Last updated 13 March 2026

What this trial tests

NA trial testing Unconditional Cash Transfer (UCT) in HIV in 100 participants. Currently enrolling.

Timeline

9 March 2026

Primary endpoint
4 January 2028

4 January 2028

Quick facts

Lead sponsor	University of Pennsylvania
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	100
Start date	9 March 2026
Primary completion	4 January 2028
Estimated completion	4 January 2028
Sites	3 locations across Botswana

Drugs / interventions tested

Unconditional Cash Transfer (UCT)

Conditions studied

HIV — all drugs for HIV →
Pregnancy — all drugs for Pregnancy →
HIV Antiretroviral Therapy (ART) Adherence — all drugs for HIV Antiretroviral Therapy (ART) Adherence →
Post-partum — all drugs for Post-partum →

Sponsor

University of Pennsylvania

Who can join

18 and older, female only, with HIV or Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to evaluate the effectiveness and implementation of an unconditional cash transfer intervention to improve mental bandwidth, ART adherence, and postpartum retention among pregnant women with HIV in Botswana. The main questions it seeks to answer are: 1. Do unconditional monthly cash transfers improve mental bandwidth relative to usual care among pregnant women with HIV? 2. Do unconditional monthly cash transfers improve ART adherence (PDC) during pregnancy and the postpartum period? 3. Is delivery of UCTs via mobile money feasible and acceptable in public ANC clinics in Botswana? 4. What barriers and facilitators affect implementation, and how should the model be adapted for a larger trial or a policy pilot (e.g., a pregnancy support grant)?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Unconditional Cash Transfer (UCT)

Trials testing the same drug.

NCT05176743 — Food Insecurity in Oncology · NA · completed

Other recruiting trials for HIV

Currently open trials in the same condition.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07226492 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 13 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07226492.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing